Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Martinuzzi

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 SubjectsEmanuela Martinuzzi, Jonathan Benzaquen, Olivier Guerin, et al.
Journal of Neuromuscular Diseases|August 30, 2021
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular DystrophyMarilyn Gros, Andreia M Nunes, Douglas Daoudlarian, et al.
Ebiomedicine|November 11, 2021
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipientsFilippo Massa, Marion Cremoni, Alexandre Gérard, et al.
Schizophrenia (Heidelberg, Germany)|December 20, 2024
Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal studyVladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 19, 2022
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trialWolfgang Strube, Aslihan Aksar, Ingrid Bauer, et al.
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Brain, Behavior, & Immunity - Health|April 26, 2022
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohortMarianne Foiselle, Susana Barbosa, Ophélia Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 SubjectsEmanuela Martinuzzi, Jonathan Benzaquen, Olivier Guerin, et al.
Journal of Neuromuscular Diseases|August 30, 2021
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular DystrophyMarilyn Gros, Andreia M Nunes, Douglas Daoudlarian, et al.
Ebiomedicine|November 11, 2021
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipientsFilippo Massa, Marion Cremoni, Alexandre Gérard, et al.
Schizophrenia (Heidelberg, Germany)|December 20, 2024
Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal studyVladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 19, 2022
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trialWolfgang Strube, Aslihan Aksar, Ingrid Bauer, et al.
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Brain, Behavior, & Immunity - Health|April 26, 2022
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohortMarianne Foiselle, Susana Barbosa, Ophélia Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 3